Ruxolitinib is an effective salvage treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation without posttransplant cyclophosphamide

2020 ◽  
Vol 100 (1) ◽  
pp. 169-180
Author(s):  
Jiao-Yu Zhao ◽  
Si-Ning Liu ◽  
Lan-Ping Xu ◽  
Xiao-Hui Zhang ◽  
Yu Wang ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document